Discontinuation rates: Despite higher absolute side effect rates, discontinuation due to adverse events is similar between medications (approximately 5-7% in trials)
Safety depends on: Personal medical history Thyroid cancer history Pancreatitis history GI sensitivity Cardiovascular risk profile Both carry boxed warnings regarding thyroid C-cell tumors observed in animal studies
Conclusion Retatrutide is a promising weight loss solution for perimenopause
At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported on Wednesday in The BMJ
At Perfect B in Doral, FL, MOTS-c protocols start with an InBody baseline, a full APRN metabolic intake, and are frequently combined with NAD+ for the mitochondrial synergy that produces the most consistent visceral fat reduction
coverage for diabetes is standard